Does POMALIDOMIDE Cause Myelosuppression? 159 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Myelosuppression have been filed in association with POMALIDOMIDE (Pomalyst). This represents 0.2% of all adverse event reports for POMALIDOMIDE.
159
Reports of Myelosuppression with POMALIDOMIDE
0.2%
of all POMALIDOMIDE reports
4
Deaths
67
Hospitalizations
How Dangerous Is Myelosuppression From POMALIDOMIDE?
Of the 159 reports, 4 (2.5%) resulted in death, 67 (42.1%) required hospitalization, and 12 (7.5%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POMALIDOMIDE. However, 159 reports have been filed with the FAERS database.
What Other Side Effects Does POMALIDOMIDE Cause?
Plasma cell myeloma (7,023)
Death (6,795)
Fatigue (6,530)
Pneumonia (5,792)
Off label use (3,845)
Diarrhoea (3,351)
White blood cell count decreased (3,328)
Neutropenia (3,029)
Rash (2,715)
Dyspnoea (2,543)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which POMALIDOMIDE Alternatives Have Lower Myelosuppression Risk?
POMALIDOMIDE vs POMALYST
POMALIDOMIDE vs PONATINIB
POMALIDOMIDE vs PONATINIB\PONATINIB
POMALIDOMIDE vs PONESIMOD
POMALIDOMIDE vs PORACTANT ALFA